Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked ...

Keywords: HIV, Gene Editing, CRISPR-Cas9, Antiviral Therapy, Genetic Engineering Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which ...

An event in Palm Springs will feature experts discussing updates in HIV research, as well as those living with HIV sharing ...

Black gay and bisexual men made up about 38% of the estimated 37,981 new HIV diagnoses in the U.S. in 2022. The Centers for Disease Control and Prevention estimates that approximately 50% of these men ...

Salisu Ahmed, a 66-year-old Nigerian man, has become the fourth person in the world to be cured of HIV (Human ...

The Catholic University of America biology professor Venigalla Rao looks at some of humanity’s great medical challenges — ...

Standard treatment of babies with HIV typically starts two to three months after birth and continues for decades. This new ...

Emory researchers are the first to show unprecedented control of SIV replication and decay of viral reservoirs by combining a ...

An estimated 39 million people might die because superbugs are able to evade medications designed to save them from disease, researchers say. Could phage therapy be the cure we need?

The goal of eliminating HIV in people living with the virus is to achieve a durable and treatment-free cure. One strategy to eradicate the virus involves boosting immune responses, particularly ...

Salisu Ahmed, a Nigerian man, has described his 31-year journey with the human immunodeficiency virus (HIV). In a recent interview with reality personality Doyin David, Ahmed disclosed that he caught ...

New research from The Wistar Institute's Montaner lab—led by Wistar Executive Vice President, director of the HIV Cure and ...